You are here

Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis

Last updated on June 19, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Atopic Dermatitis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Clinical diagnosis of chronic moderate-to-severe atopic dermatitis (AD) for at least 1
year

- Recent history of inadequate response to medicated topical therapy for AD or required
systemic therapy to control disease

- Moderate-to-severe AD defined as affected BSA at least 10%, IGA at least 3, EASI at
least 16, Peak Pruritus NRS at least 4

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- A current or pat medical history of conditions associated with thrombocytopenia,
coagulopathy, or platelet dysfunction

- Currently have active forms of other inflammatory skin diseases, i.e. not AD, or have
evidence of skin conditions (e.g. psoriasis, seborrheic dermatitis, lupus) at the time
of Day 1 that would interfere with evaluation of AD or response to treatment

- Participants who have received prior treatment with any systemic JAK inhibitors

- Require treatment with prohibited concomitant medication(s) or have received a
prohibited concomitant medication within specified time frames prior to the first dose
of study medication, including topical treatments that could affect AD

- Pregnant or breastfeeding women or sexually-active women of childbearing potential who
are unwilling to use contraception

NCT03915496
Pfizer
Not yet recruiting
Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now